Dr Jurcic on the Use of JAK Inhibitors in Myelofibrosis Management
Joseph G. Jurcic, MD, discusses the use of JAK inhibitors in the management of myelofibrosis.
Source: onclive.com
Hematologic Malignancies Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hematologic Malignancies Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hematologic Malignancies Section Today - Breaking & Trending Today
Momelotinib Efficacy Propels the Future Development of JAK Inhibitors in Myelofibrosis
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Source: onclive.com
Bio Ascend, a Vaniam Group Company, Reconvenes Inaugural Class of the "Academy of Next Wave of Investigators™" in CLL and NHL
/PRNewswire/ -- Bio Ascend, Vaniam Group's medical education company, this past weekend reconvened the inaugural class of its Academy of Next Wave of...
Source: prnewswire.com
Dr Lamanna on the Use of Novel Agents Following Progression in CLL
Nicole Lamanna, MD, discusses how the use of novel agents could address resistance associated with current treatment options for patients with chronic lymphocytic leukemia.
Source: onclive.com
Overcoming Resistance Mutations Is a Focus for Novel Therapies in R/R CLL
Nicole Lamanna, MD, discusses the challenges of resistance in patients with CLL, highlights treatment being developed for patients who progress on BTK inhibitor– or venetoclax-based regimens, and emphasizes the need for further enrollment onto clinical trials.
Source: onclive.com